课题基金 / 基金详情

Locking out HIV from CD4 T cells: A pilot study of the impact of anti a4b7 antibody (vedolizumab) on viral control following analytical treatment interruption

Locking out HIV from CD4 T cells: A pilot study of the impact of anti a4b7 antibody (vedolizumab) on viral control following analytical treatment interruption
将 HIV 与 CD4 T 细胞隔离：一项关于抗 a4b7 抗体（维多珠单抗）对分析治疗中断后病毒控制影响的初步研究
批准号：
365792
负责人：
Routy Jean-Pierre
金额：
$18.04万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-02-01 至 2018-08-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=365792&lang=en
关键词：
Anti-A4b7 Antibody Cd4 T Cells Clinical Trial Gut Damage Hiv Cure Hiv Reservoirs Hiv/Aids Innovative Methods Novel Technologies Viral Rebound

项目摘要

项目成果

Routy Jean-Pierre的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Patients suffering from IBDs present with hyperactivity of certain white blood cells (CD4 T cells) present in their intestine contributing to tissue damage. A new antibody has been developed to control these hyperactive CD4 T cells in the gut using a spec
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reversing CMV-induced gut damage to reduce inflammation and improve response to vaccine in people living with HIV
Immunosuppressive pathways and HIV reservoirs in tissues
Transsexual people: The visible and invisible persona
The orchid study: A pilot assessment of viral reservoir and immune compartmentalization in testicular tissue of HIV-infected subjects
海外基金